EI
EAM Investors’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Sell |
77,823
-52,247
| -40% | -$1.88M | 0.42% | 118 |
|
|
2025
Q1 | $5.13M | Buy |
130,070
+1,147
| +0.9% | +$45.2K | 0.89% | 9 |
|
|
2024
Q4 | $3.88M | Sell |
128,923
-47,036
| -27% | -$1.42M | 0.55% | 91 |
|
|
2024
Q3 | $4.12M | Buy |
+175,959
| New | +$4.12M | 0.62% | 66 |
|
|
2023
Q3 | – | Sell |
-84,552
| Closed | -$2.1M | – | 376 |
|
|
2023
Q2 | $2.1M | Sell |
84,552
-55,483
| -40% | -$1.38M | 0.39% | 99 |
|
|
2023
Q1 | $2.11M | Sell |
140,035
-25,412
| -15% | -$382K | 0.41% | 93 |
|
|
2022
Q4 | $1.96M | Buy |
+165,447
| New | +$1.96M | 0.41% | 95 |
|
|
2021
Q2 | – | Sell |
-58,675
| Closed | -$2.83M | – | 435 |
|
|
2021
Q1 | $2.83M | Sell |
58,675
-6,570
| -10% | -$317K | 0.43% | 56 |
|
|
2020
Q4 | $3.39M | Sell |
65,245
-31,235
| -32% | -$1.62M | 0.56% | 32 |
|
|
2020
Q3 | $2.58M | Sell |
96,480
-59,604
| -38% | -$1.6M | 0.61% | 32 |
|
|
2020
Q2 | $3.04M | Buy |
+156,084
| New | +$3.04M | 0.67% | 24 |
|
|
2017
Q4 | – | Sell |
-308,120
| Closed | -$3.65M | – | 345 |
|
|
2017
Q3 | $3.65M | Sell |
308,120
-5,067
| -2% | -$60K | 0.49% | 56 |
|
|
2017
Q2 | $3.15M | Sell |
313,187
-17,763
| -5% | -$179K | 0.52% | 61 |
|
|
2017
Q1 | $3.86M | Buy |
+330,950
| New | +$3.86M | 0.61% | 28 |
|
|
2015
Q3 | – | Sell |
-410,689
| Closed | -$6.81M | – | 337 |
|
|
2015
Q2 | $6.81M | Buy |
410,689
+8,814
| +2% | +$146K | 0.8% | 5 |
|
|
2015
Q1 | $6.22M | Sell |
401,875
-28,752
| -7% | -$445K | 0.72% | 5 |
|
|
2014
Q4 | $6.82M | Buy |
430,627
+176,734
| +70% | +$2.8M | 0.95% | 2 |
|
|
2014
Q3 | $2.71M | Buy |
253,893
+117,501
| +86% | +$1.25M | 0.55% | 28 |
|
|
2014
Q2 | $1.28M | Buy |
+136,392
| New | +$1.28M | 0.24% | 219 |
|